Selected article for: "acute respiratory syndrome and administration require"
Author: Fontana, Francesco; Alfano, Gaetano; Mori, Giacomo; Amurri, Alessio; Tei, Lorenzo; Ballestri, Marco; Leonelli, Marco; Facchini, Francesca; Damiano, Francesca; Magistroni, Riccardo; Cappelli, Gianni
Title: COVID‐19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine
  • Cord-id: i66kfldg
  • Document date: 2020_5_13
    • ID: i66kfldg
    Snippet: Coronavirus disease 2019 (COVID‐19) pneumonia has been poorly reported in solid organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61‐year‐old kidney transplant recipient with several comorbidities who was hospitalized and later received a diagnosis of COVID‐19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of tocilizumab, after immunosuppression reduction; the patien
    Document: Coronavirus disease 2019 (COVID‐19) pneumonia has been poorly reported in solid organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61‐year‐old kidney transplant recipient with several comorbidities who was hospitalized and later received a diagnosis of COVID‐19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation. During the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic, transplant clinicians should be readily informed about new cases of COVID‐19 pneumonia in solid organ transplant recipients, with focus on therapeutic strategies employed and their outcome.

    Search related documents:
    Co phrase search for related documents
    • absolute lymphocyte count and active infection: 1
    • absolute lymphocyte count and acute respiratory distress syndrome: 1, 2, 3, 4
    • absolute lymphocyte count and acute respiratory distress syndrome develop: 1
    • absolute lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absolute lymphocyte count leukocyte and lymphocyte count: 1, 2, 3, 4
    • active infection and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • active infection and acute respiratory distress syndrome develop: 1
    • active infection and additional dose: 1
    • active infection and administered dose: 1, 2
    • active infection and low micromolar: 1
    • active infection and lung damage: 1, 2, 3, 4, 5, 6
    • active infection and lymphocyte count: 1, 2, 3
    • acute respiratory distress syndrome and administered dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute respiratory distress syndrome and admission collect: 1
    • acute respiratory distress syndrome and low flow oxygen: 1, 2, 3
    • acute respiratory distress syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome develop and administered dose: 1
    • acute respiratory distress syndrome develop and admission collect: 1